Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Stevens

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Journal of Diabetes and Its Complications|December 13, 2002
UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetesRichard J Stevens, Irene M Stratton, Rury R Holman, et al.
Plos One|July 8, 2025
Exploring the variation in muscle response testing accuracy through repeatability and reproducibilityAnne M Jensen, Richard J Stevens, Amanda J Burls
BMC Complementary and Alternative Medicine|December 2, 2016
Estimating the accuracy of muscle response testing: two randomised-order blinded studiesAnne M Jensen, Richard J Stevens, Amanda J Burls
Plos One|March 27, 2014
Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication changeJennifer A Hirst, Richard J Stevens, Andrew J Farmer
Complementary Medicine Research|April 19, 2019
The Impact of Using Emotionally Arousing Stimuli on Muscle Response Testing AccuracyAnne M Jensen, Richard J Stevens, Amanda J Burls
Journal of Hypertension|September 21, 2018
The utility of long-term blood pressure variability for cardiovascular risk prediction in primary careSarah L Stevens, Richard J McManus, Richard J Stevens
Journal of Evaluation in Clinical Practice|August 26, 2018
Is "chronic kidney disease" a disease?Benjamin T H Smart, Richard J Stevens, Jan Y Verbakel
Statistical Methods in Medical Research|March 20, 2016
Methods for meta-analysis of pharmacodynamic dose-response data with application to multi-arm studies of alogliptinOliver Langford, Jeffrey K Aronson, Gert van Valkenhoef, et al.
Diabetes Care|February 10, 2007
Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetesRuth L Coleman, Richard J Stevens, Ravi Retnakaran, et al.
Drug Safety|January 22, 2022
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of PublicityRobin E Ferner, Richard J Stevens, Christopher Anton, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Journal of Diabetes and Its Complications|December 13, 2002
UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetesRichard J Stevens, Irene M Stratton, Rury R Holman, et al.
Plos One|July 8, 2025
Exploring the variation in muscle response testing accuracy through repeatability and reproducibilityAnne M Jensen, Richard J Stevens, Amanda J Burls
BMC Complementary and Alternative Medicine|December 2, 2016
Estimating the accuracy of muscle response testing: two randomised-order blinded studiesAnne M Jensen, Richard J Stevens, Amanda J Burls
Plos One|March 27, 2014
Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication changeJennifer A Hirst, Richard J Stevens, Andrew J Farmer
Complementary Medicine Research|April 19, 2019
The Impact of Using Emotionally Arousing Stimuli on Muscle Response Testing AccuracyAnne M Jensen, Richard J Stevens, Amanda J Burls
Journal of Hypertension|September 21, 2018
The utility of long-term blood pressure variability for cardiovascular risk prediction in primary careSarah L Stevens, Richard J McManus, Richard J Stevens
Journal of Evaluation in Clinical Practice|August 26, 2018
Is "chronic kidney disease" a disease?Benjamin T H Smart, Richard J Stevens, Jan Y Verbakel
Statistical Methods in Medical Research|March 20, 2016
Methods for meta-analysis of pharmacodynamic dose-response data with application to multi-arm studies of alogliptinOliver Langford, Jeffrey K Aronson, Gert van Valkenhoef, et al.
Diabetes Care|February 10, 2007
Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetesRuth L Coleman, Richard J Stevens, Ravi Retnakaran, et al.
Drug Safety|January 22, 2022
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of PublicityRobin E Ferner, Richard J Stevens, Christopher Anton, et al.
Pageof 6